Neurology MS Drug Launch Contract?

Discussion in 'Syneos Health' started by anonymous, Jun 30, 2020 at 9:20 PM.

Tags: Add Tags
  1. Steve Long

    Steve Long Guest

    Did they finish hiring for the New England area?
     

  2. anonymous

    anonymous Guest

    Offers will be in mid 70's plus a car and 25000 bonus uncapped
     
  3. anonymous

    anonymous Guest

    No you are obviously the one trolling. Offers have been made and if you knew anything about MS market you would know what a hard sell it will be.
     
  4. anonymous

    anonymous Guest

    Haha. If u can't sell a drug with superior results vs a main competitor you prob shouldn't be in MS.
     
  5. anonymous

    anonymous Guest

    Haha You prob saw me finish 10th at Harlem special Olympics or giving head at pride fest.
     
  6. anonymous

    anonymous Guest

    Offers are being made this week and next. Salary is 100-120k, maybe more with experience in the MS market. 35 k at plan with bonus, company car, 401k, blah, blah.....you know the rest.
    Drug is sell able, one of the better S1Ps, head to head vs Aubagio, good secondary data.
    You can either sell in this market or you can't, highly competitive so if you're a lazy 11 to 2 rep you won't last. Start date week after Labor Day I believe. Good luck...
     
  7. anonymous

    anonymous Guest

    Unfortunately this drug did not get approved and people on the MS team are leaving. The writing is on the wall, layoffs coming very soon. the new leader is a joke and the Janssen guy KP, mr. Military, does;t have a clue. He is a command and control type who does not under stand health care nor the concept of COVID restrictions. All the people around him are yes men!!!!!!!!
     
  8. anonymous

    anonymous Guest

    The drug is approved.
     
  9. anonymous

    anonymous Guest

    You must have been fired during training. Approved on March 18. Launch is over. Reps selling now.
     
  10. anonymous

    anonymous Guest

    Selling a loose word for it. So far most scripts have come from speakers whom Janssen has done a poor job of choosing. Stay away. People leaving. 4th drug to market with no real advantages. Good luck with this.
     
  11. anonymous

    anonymous Guest

    This is right on about most upper management. Especially KP. Not true about men, this company is too diverse and woke. If you a halfway competent woman you will succeed here (DL).